The Library
Approaches to sample size calculation for clinical trials in rare diseases
Tools
Tools
Tools
Miller, Frank, Zohar, Sarah, Stallard, Nigel, Madan, Jason, Posch, Martin, Hee, Siew Wan, Pearce , Michael, Vågerö, Mårten and Day, Simon (2018) Approaches to sample size calculation for clinical trials in rare diseases. Pharmaceutical Statistics, 17 (3). pp. 214-230. doi:10.1002/pst.1848
|
PDF
WRAP-approaches-sample-size-calculation-clinical-trials-diseases-Stallard-2017.pdf - Accepted Version - Requires a PDF viewer. Download (1607Kb) | Preview |
Official URL: http://doi.org/10.1002/pst.1848
Abstract
We discuss 3 alternative approaches to sample size calculation: traditional sample size calculation based on power to show a statistically significant effect, sample size calculation based on assurance, and sample size based on a decision-theoretic approach. These approaches are compared head-to-head for clinical trial situations in rare diseases. Specifically, we consider 3 case studies of rare diseases (Lyell disease, adult-onset Still disease, and cystic fibrosis) with the aim to plan the sample size for an upcoming clinical trial. We outline in detail the reasonable choice of parameters for these approaches for each of the 3 case studies and calculate sample sizes. We stress that the influence of the input parameters needs to be investigated in all approaches and recommend investigating different sample size approaches before deciding finally on the trial size. Highly influencing for the sample size are choice of treatment effect parameter in all approaches and the parameter for the additional cost of the new treatment in the decision-theoretic approach. These should therefore be discussed extensively.
| Item Type: | Journal Article | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > R Medicine (General) | ||||||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School |
||||||||
| Library of Congress Subject Headings (LCSH): | Clinical trials -- Mathematical models, Rare diseases, Toxic epidermal necrolysis, Cystic fibrosis | ||||||||
| Journal or Publication Title: | Pharmaceutical Statistics | ||||||||
| Publisher: | John Wiley & Sons Ltd. | ||||||||
| ISSN: | 1539-1604 | ||||||||
| Official Date: | 1 May 2018 | ||||||||
| Dates: |
|
||||||||
| Date of first compliant deposit: | 14 December 2017 | ||||||||
| Volume: | 17 | ||||||||
| Number: | 3 | ||||||||
| Page Range: | pp. 214-230 | ||||||||
| DOI: | 10.1002/pst.1848 | ||||||||
| Status: | Peer Reviewed | ||||||||
| Publication Status: | Published | ||||||||
| Access rights to Published version: | Restricted or Subscription Access | ||||||||
| RIOXX Funder/Project Grant: |
|
||||||||
| Related URLs: |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
